Robert Jappie

 Life Science & Cannabis Regulation at Ince

Robert Jappie is a partner in the London office at Ince, specialising in Life Sciences and Cannabis Regulation for the UK and Europe. Robert is able to provide advice and expertise in relation to the following matters:

• CBD Regulation and Compliance
• Cannabis Based Medicinal Products (CBPMs) – routes to market
• EU Novel Food Regulations and Marketing Authorisation Submissions
• Cultivation license applications
• Cosmetic product regulations
• Healthcare and Health-tech regulatory submissions
• Covid-19 related regulatory approvals
• Medical Device approval
• Product Compliance and Formulation
• Import/Export best practice
• POCA concerns for the Cannabis investment sector
• Psychedelics

New industries present new opportunities, and with these opportunities arise new risks. The risk is one of regulatory intervention. If managed correctly, such regulatory interventions can be turned into an opportunity for a business to improve its compliance and develop a longstanding, positive relationship with the relevant regulators. Robert’s expertise in making regulatory applications, obtaining regulatory approvals and defending interventions can mitigate these risks in order to allow innovation to flourish. Robert has advised companies in relation to licensing and
regulatory submissions to the MHRA, FSA, CQC and the Home Office. Due to his unique expertise he has become a leading legal expert in the European cannabis industry and has re-enforced the firm’s position as a global leader in Regulatory Solutions.

social media: